SKI Market

Indian Indices

Nifty

22,055.20 97.70
(0.44%)

Sensex

72,664.47 260.30
( 0.36%)

Bank Nifty

47,421.10 -66.80
( -0.14%)

Nifty IT

32,935.15 -270.70
( -0.82%)

Global Indices

Nasdaq

16,346.27 43.51
(0.27%)

Dow Jones

39,387.76 331.37
(0.85%)

Hang Seng

18,963.68 425.87
(2.30%)

Nikkei 225

38,229.11 155.13
(0.41%)

Forex

USD-INR

83.47 0.00
(-0.01%)

EUR-INR

89.79 -0.06
(-0.07%)

GBP-INR

104.34 -0.31
(-0.29%)

JPY-INR

0.54 0.00
(-0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01023

1453.1267897

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

22.59

98073.29

EPS(TTM)

Face Value()

Div & Yield %

260.28

0.68

Back

ruchira papers ltd

Ruchira Papers standalone net profit declines 58.18% in the December 2023 quarter

Feb 12,2024

Net profit of Ruchira Papers declined 58.18% to Rs 7.21 crore in the quarter ended December 2023 as against Rs 17.24 crore during the previous quarter ended December 2022. Sales declined 21.67% to Rs 158.52 crore in the quarter ended December 2023 as against Rs 202.38 crore during the previous quarter ended December 2022.

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	158.52	202.38	-22
OPM %	8.56	13.61	-
PBDT	13.73	26.94	-49
PBT	9.69	23.11	-58
NP	7.21	17.24	-58

22,055.20 97.70 (0.44%)

72,664.47 260.30 ( 0.36%)

47,421.10 -66.80 ( -0.14%)

32,935.15 -270.70 ( -0.82%)

16,346.27 43.51 (0.27%)

39,387.76 331.37 (0.85%)

18,963.68 425.87 (2.30%)

38,229.11 155.13 (0.41%)

83.47 0.00 (-0.01%)

89.79 -0.06 (-0.07%)

104.34 -0.31 (-0.29%)

0.54 0.00 (-0.73%)